MedTrace Logo

Primary Immunodeficiencies in Costa Rican Adults

NCT04963660 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2021-07-15

No results posted yet for this study

Summary

Primary immunodeficiencies represent a underdiagnosed group of rare diseases which if diagnosed well and in time can be treated in an efficient manner and prevent complications that may affect the quality of patients life in an severe manner. Neither in Costa Rica nor in Central America studies or national registries regarding the prevalence and characterization of primary immunodeficiencies in adult patients exist up to now. This study reflects for the first time the epidemiologic situation of primary immunodeficiencies in a Central American country, characterizing adult patients diagnosed with primary and idiopathic immune disorders treated in two specialized immunodeficiency clinics in Costa Rica.

Conditions

  • Primary Immune Deficiency in Adults

Sponsors & Collaborators

  • Caja Costarricense de Seguro Social

    lead OTHER_GOV

Eligibility

Min Age
12 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-11
Primary Completion
2019-11-11
Completion
2019-11-11

Countries

  • Costa Rica

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04963660 on ClinicalTrials.gov